Megestrol acetate in pediatric oncology patients may lead to severe, symptomatic adrenal suppression
Open Access
- 2 July 2003
- Vol. 98 (2) , 397-405
- https://doi.org/10.1002/cncr.11502
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Effects of megestrol acetate on weight gain, body composition, and pulmonary function in patients with cystic fibrosisThe Journal of Pediatrics, 2002
- Randomized, Double-Blind, Placebo-Controlled Pilot Trial of Megestrol Acetate in Malnourished Children With Cystic FibrosisJournal of Pediatric Gastroenterology and Nutrition, 2000
- Treatment of anorexia and weight loss with megestrol acetate in patients with cystic fibrosisPediatric Pulmonology, 1999
- A randomised phase III cross-over study of tamoxifen versus megestrol acetate in advanced and recurrent breast cancerEuropean Journal Of Cancer, 1996
- Megestrol acetate therapy for anorexia and weight loss in children with malignant solid tumoursAlimentary Pharmacology & Therapeutics, 1996
- Prospective randomised trial of two dose levels of megestrol acetate in the management of anorexia-cachexia syndrome in patients with metastatic cancerBritish Journal of Cancer, 1996
- A prospective randomized trial to evaluate different oral dose regimens of medroxyprogesterone acetate in women with advanced breast cancerClinical Oncology, 1995
- Megestrol Acetate in Patients with AIDS and CachexiaAnnals of Internal Medicine, 1994
- MEGESTROL ACETATE FOR TREATMENT OF ANOREXIA ASSOCIATED WITH HUMAN IMMUNODEFICIENCY VIRUS INFECTION IN CHILDRENThe Pediatric Infectious Disease Journal, 1994
- Medical castration using megestrol acetate and minidose estrogenUrology, 1988